Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 1/20 | 0.37 |
| ▸ | HTR2B | P41595 | 1/20 | 0.37 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.36 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.36 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.35 |
| ▸ | USP5 | P45974 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.34 |
| ▸ | CCR2 | P41597 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7756551 | 1.00 | CYP2C9 (0.40) | CYP2C9ESR2ALDH1A1LMNAMAPT | |
| SCHEMBL8452150 | 1.00 | CYP2C9 (0.40) | CYP2C9ESR2ALDH1A1LMNAMAPT | |
| SCHEMBL12012971 | 0.95 | CYP2C9 (0.38) | CYP2C9ESR2ALDH1A1LMNAMAPT | |
| SCHEMBL18511908 | 0.95 | CYP2C9 (0.38) | CYP2C9ESR2ALDH1A1LMNAMAPT | |
| SCHEMBL8467336 | 0.95 | HTR2A (0.40) | CYP2C9ESR2HTR2AHTR2CHTR2B | |
| SCHEMBL5683749 | 0.90 | HTR2A (0.37) | CYP2C9ESR2HTR2AHTR2CHTR2B | |
| SCHEMBL18511910 | 0.90 | HTR2A (0.37) | CYP2C9ESR2HTR2AHTR2CHTR2B | |
| SCHEMBL7594396 | 0.90 | CYP2C9 (0.50) | CYP2C9ESR2ALDH1A1LMNAMAPT | |
| SCHEMBL7507561 | 0.90 | CYP2C9 (0.50) | CYP2C9ESR2ALDH1A1LMNAMAPT | |
| SCHEMBL8452476 | 0.90 | CYP2C9 (0.50) | CYP2C9ESR2ALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11193066-B2 | Polymerizable compound and composition, liquid crystal composite, optical anisotropic body, liquid crystal display device and use thereof | JNC CORPORATION (JP) | 2021-12-07 | — | — | US | disclosed |
| US-20210214615-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT | JNC CORPORATION (JP) | 2021-07-15 | — | — | US | disclosed |
| EP-3722278-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC Corporation (JP) | 2020-10-14 | — | — | EP | disclosed |
| US-20200299578-A1 | POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2020-09-24 | — | — | US | disclosed |
| US-10759998-B2 | Polymerizable polar compound, liquid crystal composition and liquid crystal display element | JNC CORPORATION (JP) | 2020-09-01 | — | — | US | disclosed |
| EP-3495450-B1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORP (JP) | 2020-08-05 | — | — | EP | disclosed |
| US-20200239775-A1 | TETRACYCLIC LIQUID CRYSTAL COMPOUND HAVING DIATOMIC BONDING GROUP AND 2,3-DIFLUOROPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2020-07-30 | — | — | US | disclosed |
| US-10676669-B2 | Compound having naphthalene ring, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2020-06-09 | — | — | US | disclosed |
| US-10662379-B2 | Polymerizable polar compound, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2020-05-26 | — | — | US | disclosed |
| US-10563126-B2 | Liquid crystal compound having benzothiophene, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2020-02-18 | — | — | US | disclosed |
| EP-0728829-A2 | Liquid crystalline alkenylcyclohexene derivative, liquid crystal composition and liquid crystal display element | CHISSO CORPORATION (JP) | 1996-08-28 | — | — | EP | disclosed |
| EP-0718387-A1 | A liquid crystal composition and a liquid crystal display element which contains it | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1996-06-26 | — | — | EP | disclosed |
| EP-0718264-A1 | A liquid crystalline compound containing fluorine atom substituted alkyl group(s) and a liquid crystal composition | Chisso Corporation (JP) | 1996-06-26 | — | — | EP | disclosed |
| EP-0704512-A1 | A liquid crystal composition and a liquid crystal display element using the same | Chisso Corporation (JP) | 1996-04-03 | — | — | EP | disclosed |
| US-5496501-A | Silacyclohexane compound, a method of preparing it and a liquid crystal composition containing it | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1996-03-05 | — | — | US | disclosed |
| EP-0688754-A1 | DICYCLOHEXYLETHYLENE DERIVATIVE | CHISSO CORPORATION (JP) | 1995-12-27 | — | — | EP | disclosed |
| EP-0675187-A2 | Liquid crystalline compounds and liquid crystal composition | Chisso Corporation (JP) | 1995-10-04 | — | — | EP | disclosed |
| EP-0672742-A1 | A hexenediyne derivative and a liquid crystal composition | CHISSO CORPORATION (JP) | 1995-09-20 | — | — | EP | disclosed |
| EP-0657460-A1 | A silacyclohexane compound, a method of prepraring it and a liquid crystal composition containing it | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1995-06-14 | — | — | EP | disclosed |
| EP-0640578-A1 | Novel liquid crystalline compound having a 1,1,2,3,3,3,-hexafluoropropyl group and liquid crystal composition | Chisso Corporation (JP) | 1995-03-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11193066-B2 | Polymerizable compound and composition, liquid crystal composite, optical anisotropic body, liquid crystal display device and use thereof | OCIAD2, PYM1, C1S | CYP2C9 3551/4885ESR2 4495/4885ALDH1A1 4091/4885 |
| US-10662379-B2 | Polymerizable polar compound, liquid crystal composition and liquid crystal display device | SP1, MBD2, PAXBP1 | CYP2C9 3761/4885ESR2 1970/4885ALDH1A1 3826/4885 |
| US-10676669-B2 | Compound having naphthalene ring, liquid crystal composition and liquid crystal display device | PYM1, CXCR1, CPNE4 | CYP2C9 760/4885ESR2 1913/4885ALDH1A1 2514/4885 |
| US-10759998-B2 | Polymerizable polar compound, liquid crystal composition and liquid crystal display element | SP1, SFXN3, SFXN1 | CYP2C9 4664/4885ESR2 2449/4885ALDH1A1 3968/4885 |
| US-20200299578-A1 | POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | SP1, CCND1, CPNE4 | CYP2C9 3951/4885ESR2 1627/4885ALDH1A1 1924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.